semaglutide dark web Internet searches on weight-loss medications have increased 25-fold since the launch of GLP-1 drugs Modulation of metabolic, inflammatory and

Greek-Inspired Flavors garlic, lemon, and herbs give a Mediterranean twist

A 2024 study published in Nutrients found that GLP-1 receptor agonists alter gut microbiota by promoting beneficial species like Bacteroides , Akkermansia , and Ruminococcus while reducing potentially harmful bacteria

most injectable formulations remain potent for 30-90 days when properly stored

For healthcare providers, this comparative effectiveness study offers important data to inform prescribing decisions

Yazen, which launched its weight loss service in 2022, initially set out to exclusively target obese men, but broadened its focus before launching to include obesity more generally, after seeing how effective GLP-1 drugs were, says CEO Fredrik Meurling

Flavonoids and alkenyl benzenes: new concepts in bioactivation studies